$5.85
-0.14-2.34%
Pre-Market: 8:42 AM EDT
Comments
Loading...
Altimmune Stock Guidance | NASDAQ:ALT | Benzinga
Altimmune issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Altimmune (ALT)?
There have been no specific sales or earnings guidance reported for Altimmune in recent months.
Browse guidance and forecast on all stocks.